Relay Therapeutics Inc (RLAY) is a biotechnology company listed on NASDAQ.
Latest reported RLAY revenue for 2026-06-30 was $3.4M. Net income was -$157.0M. Revenue was up 11.7% from 2026-03-31 to 2026-06-30. RLAY currently screens at market cap $3.39B.
Use this RLAY page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the RLAY quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the RLAY SEC filings page. Lician reads the product cache first so this HTML stays unique to Relay Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full RLAY income, balance, and cash tables.